Fig. 8
Hematoxylin and eosin staining in leukemia-infiltrated tissues after treatment with T22-GFP-H6-Auristatin. Hematoxylin and eosin staining of the liver, spleen, bone marrow, lung, pancreas, brain, heart, and kidneys of mice treated with vehicle (VEH) or T22-GFP-H6-Auristatin (T22-AUR) 14 days after the injection of CXCR4+ THP-1-Luci cells in NSG mice, compared with the stained tissues of a healthy mouse (Normal). T22-AUR, T22-GFP-H6-Auristatin group; VEH, vehicle group